Cite
HARVARD Citation
Watanabe, M. et al. (n.d.). Novel MEK inhibitor trametinib and other retinoblastoma gene (RB)‐reactivating agents enhance efficacy of 5‐fluorouracil on human colon cancer cells. Cancer science. 104 (6), pp. 687-693. [Online].